Eucrates Biomedical Acquisition Corp. (EUCR)

NASDAQ: EUCR · IEX Real-Time Price · USD
9.78
0.01 (0.10%)
Jan 28, 2022 11:53 AM EST - Market open
Market Cap131.63M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out13.46M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,855
Open9.77
Previous Close9.77
Day's Range9.75 - 9.79
52-Week Range9.59 - 10.88
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About EUCR

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

IndustryBlank Check / SPAC
IPO DateOct 23, 2020
Employees4
Stock ExchangeNASDAQ
Ticker SymbolEUCR
Full Company Profile

News

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

NEW YORK, June 1, 2021 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exc...

7 months ago - PRNewsWire

Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering

NEW YORK, Oct. 27, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset a...

1 year ago - PRNewsWire

Eucrates Biomedical Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

NEW YORK, Oct. 23, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset a...

1 year ago - PRNewsWire